Skip to content
Home
Anaemia of CKD
Executive Summary
About this guideline
Introduction
Background
References
Summary of Clinical Practice Guidelines
Assessment for Anaemia of CKD (Guidelines 1.1 – 1.5)
Treatment of Anaemia of CKD with Iron (Guidelines 2.1 – 2.7)
Treatment of Anaemia with Erythropoiesis Stimulating Agents (Guidelines 3.1 – 3.17)
Treatment of Anaemia with HIF-PHI Agents (Guidelines 4.1 – 4.9)
Treatment of Anaemia of CKD with Blood Transfusions (Guidelines 5.1 – 5.1.3)
Management of Peri-Transplant and Post-Transplant Anaemia (Guidelines 6.1 – 6.3.3)
Special Populations (Guidelines 7.1 – 7.3)
Summary of Audit Measures on Anaemia of CKD
Summary of Research Recommendations
Rationale for Clinical Practice Guidance
New Therapies for Consideration in the Future
Lay Summary
Patient Information Leaflet for Anaemia of CKD
Authors
Guidelines
Anaemia of CKD Guideline
Blood Pressure
Haemodialysis
Hyperkalaemia
SGLT-2
Guidelines Library
Linkedin Instagram Youtube Facebook
Home
Management of Blood Pressure
Introduction
Summary of Clinical Practice Guidelines
Rationale for Clinical Practice Guidelines
Summary of audit measures
Summary of research recommendations
Lay Summary
Appendix A
Appendix B
Appendix C
Appendix D
Appendix E
Authors
Guidelines
Anaemia of CKD
Blood Pressure
Haemodialysis
Hyperkalaemia
SGLT-2
Guidelines Library
Navigate to sections
Home
Anaemia of CKD
Executive Summary
About this guideline
Introduction
Background
References
Summary of Clinical Practice Guidelines
Assessment for Anaemia of CKD (Guidelines 1.1 – 1.5)
Treatment of Anaemia of CKD with Iron (Guidelines 2.1 – 2.7)
Treatment of Anaemia with Erythropoiesis Stimulating Agents (Guidelines 3.1 – 3.17)
Treatment of Anaemia with HIF-PHI Agents (Guidelines 4.1 – 4.9)
Treatment of Anaemia of CKD with Blood Transfusions (Guidelines 5.1 – 5.1.3)
Management of Peri-Transplant and Post-Transplant Anaemia (Guidelines 6.1 – 6.3.3)
Special Populations (Guidelines 7.1 – 7.3)
Summary of Audit Measures on Anaemia of CKD
Summary of Research Recommendations
Rationale for Clinical Practice Guidance
New Therapies for Consideration in the Future
Lay Summary
Patient Information Leaflet for Anaemia of CKD
Authors
Guidelines
Anaemia of CKD Guideline
Blood Pressure
Haemodialysis
Hyperkalaemia
SGLT-2
Guidelines Library
  • Introduction
  • Summary of clinical practice guidelines
    • Measurement of blood pressure
    • Blood pressure targets
    • Lifestyle modification
    • Dialysis and Dialysate
    • Dry weight optimization
    • Medication
    • Children & Young People (CYP)
    • Practice Points
  • Rationale for clinical practice guidelines
    • Measurement of blood pressure
    • Diagnosis
    • Monitoring
    • Blood Pressure Targets
    • Lifestyle modification
    • Dialysis and Dialysate
    • Dry weight optimization
    • Medication
    • Children and Young People (CYP)
  • Summary of audit measures
  • Summary of research recommendations
  • Lay Summary
  • Appendix A
  • Appendix B
  • Appendix C
    • Blood Pressure Measurement
    • Blood Pressure Targets
    • Lifestyle Modification
    • Dialysis and Dialysate
    • Dry Weight
    • Medication
    • Children & Young People
  • Appendix D
  • Appendix E
Home
Management of Blood Pressure
Rationale for Clinical Practice Guidelines

Rationale for Clinical Practice Guidelines

Measurement of blood pressure

Diagnosis

Monitoring

Blood Pressure Targets

Lifestyle modification

Dialysis and Dialysate

Dry weight optimisation

Medication

Children and Young People (CYP)

 

About the UKKA
Contact Us
About the UKKA
Contact Us

2026 The UK Kidney Association. All rights reserved